These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 32727324)
1. The Chemistry of Triazine Isomers: Structures, Reactions, Synthesis and Applications. Kushwaha N; Sharma CS Mini Rev Med Chem; 2020; 20(20):2104-2122. PubMed ID: 32727324 [TBL] [Abstract][Full Text] [Related]
2. Heterocyclic Compounds Bearing Triazine Scaffold and Their Biological Significance: A Review. Verma T; Sinha M; Bansal N Anticancer Agents Med Chem; 2020; 20(1):4-28. PubMed ID: 31746306 [TBL] [Abstract][Full Text] [Related]
3. Privileged s-triazines: structure and pharmacological applications. Shah DR; Modh RP; Chikhalia KH Future Med Chem; 2014 Mar; 6(4):463-77. PubMed ID: 24635525 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological activities of arylmethylamine substituted chlorotriazine and methylthiotriazine compounds. Zhao H; Liu Y; Cui Z; Beattie D; Gu Y; Wang Q J Agric Food Chem; 2011 Nov; 59(21):11711-7. PubMed ID: 21970768 [TBL] [Abstract][Full Text] [Related]
5. 1,3,5-Triazine: A versatile pharmacophore with diverse biological activities. Singh S; Mandal MK; Masih A; Saha A; Ghosh SK; Bhat HR; Singh UP Arch Pharm (Weinheim); 2021 Jun; 354(6):e2000363. PubMed ID: 33760298 [TBL] [Abstract][Full Text] [Related]
6. Recent Advances in the Biological Activity of s-Triazine Core Compounds. Maliszewski D; Drozdowska D Pharmaceuticals (Basel); 2022 Feb; 15(2):. PubMed ID: 35215333 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and antitumor activities of 1,2,3-triazines and their benzo- and heterofused derivatives. Cascioferro S; Parrino B; Spanò V; Carbone A; Montalbano A; Barraja P; Diana P; Cirrincione G Eur J Med Chem; 2017 Dec; 142():74-86. PubMed ID: 28615111 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of novel 2,4,6-triazine derivatives as antimicrobial agents. Gavade SN; Markad VL; Kodam KM; Shingare MS; Mane DV Bioorg Med Chem Lett; 2012 Aug; 22(15):5075-7. PubMed ID: 22742908 [TBL] [Abstract][Full Text] [Related]
9. 1,2,3-Triazine scaffold as a potent biologically active moiety: a mini review. Kumar R; Singh AD; Singh J; Singh H; Roy RK; Chaudhary A Mini Rev Med Chem; 2014 Jan; 14(1):72-83. PubMed ID: 24387709 [TBL] [Abstract][Full Text] [Related]
10. An overview on the recent developments of 1,2,4-triazine derivatives as anticancer compounds. Cascioferro S; Parrino B; Spanò V; Carbone A; Montalbano A; Barraja P; Diana P; Cirrincione G Eur J Med Chem; 2017 Dec; 142():328-375. PubMed ID: 28851503 [TBL] [Abstract][Full Text] [Related]
11. Triazine as a promising scaffold for its versatile biological behavior. Singla P; Luxami V; Paul K Eur J Med Chem; 2015 Sep; 102():39-57. PubMed ID: 26241876 [TBL] [Abstract][Full Text] [Related]
12. Derivatives of the new ring system indolo[1,2-c]benzo[1,2,3]triazine with potent antitumor and antimicrobial activity. Cirrincione G; Almerico AM; Barraja P; Diana P; Lauria A; Passannanti A; Musiu C; Pani A; Murtas P; Minnei C; Marongiu ME; La Colla P J Med Chem; 1999 Jul; 42(14):2561-8. PubMed ID: 10411476 [TBL] [Abstract][Full Text] [Related]
13. Synthetic and pharmacological developments in the hybrid s-triazine moiety: A review. Bareth D; Jain S; Kumawat J; Kishore D; Dwivedi J; Hashmi SZ Bioorg Chem; 2024 Feb; 143():106971. PubMed ID: 38016395 [TBL] [Abstract][Full Text] [Related]